Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 4 × Vomiting × Ondansetron × Clear all

Phase

Phase 3 12 Phase 2 7 Phase NA 5 Phase 4 2 Phase EARLY_PHASE1 1

Status

Unknown 1 Completed 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Vomiting 2 Neoplasms 2 Nausea 2 Thyroid Neoplasms 1 Prostatic Neoplasms 1

Interventions

Aprepitant 8 Palonosetron 5 Dexamethasone 5 Granisetron 3 fosaprepitant 2 dexamethasone 21-phosphate 2 Tropisetron 2 Ondansetron 2 Metoclopramide 2 Calcium Dobesilate 2 ramosetron 1 naldemedine 1 dolasetron 1 dexamethasone acetate 1 alizapride 1 Tablets 1 Saline Solution 1 Olanzapine 1 Duration of Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01636947 2018-09-25

KMEC

Merck Sharp & Dohme LLC

Phase 4 Completed

494 enrolled 14 charts

Nausea, Neoplasms, Vomiting

NCT01913990 2017-01-30

ER11-02

Ottawa Hospital Research Institute

Phase 4 Unknown

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡